FMP
Akouos, Inc.
AKUS
NASDAQ
Inactive Equity
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. The company was incorporated in 2016 and is based in Boston, Massachusetts.
13.29 USD
0 (0%)
AKUS Financial Statements
Year
2021
2020
2019
2018
Total Revenue
0
0
0
0
Cost of Revenue
0
0
0
0
Gross Profit
0
0
0
0
Operating Expenses
86.82M
48.88M
23.88M
7.42M
Research and Development
64.59M
34.3M
20.47M
5.64M
Selling, General & Administrative Expenses
22.23M
14.58M
3.41M
1.78M
Selling & Marketing Expenses
0
0
0
0
General & Administrative Expenses
22.23M
14.58M
3.41M
1.78M
Other Expenses
0
0
0
0
Operating Income
-86.67M
-48.88M
-23.88M
-7.42M
Total Other Income/Expenses Net
150k
280k
-1.86M
1.41M
Income Before Tax
-86.67M
-48.6M
-25.74M
-6.01M
Income Tax
150k
280k
-1.86M
1.41M
Net Income
-86.67M
-48.6M
-25.74M
-6.01M
Basic EPS
-4.94
-2.77
-4
-0.93
EPS Diluted
-4.94
-2.77
-4
-0.93
Basic Average Shares
17.55M
17.55M
6.43M
6.43M
Diluted Average Shares
17.55M
17.55M
6.43M
6.43M
EBITDA
-82.92M
-48.88M
-25.04M
-5.96M
Retained Earning Schedule
Year
2021
2020
2019
Retained Earnings (Previous Year)
-81.72M
-33.12M
-7.38M
Net Income
-86.67M
-48.6M
-25.74M
Stock Repurchases
35k
0
0
Dividend Paid
0
0
0
Retained Earnings
-168.4M
-81.72M
-33.12M
Other Distributions
-86.64M
-48.6M
-25.74M
PPE Schedule
Year
2021
2020
2019
Gross PPE
40.14M
21.35M
0
Annual Depreciation
3.75M
2.17M
697k
Capital Expenditure
-9.02M
-4.53M
-3.44M
Net PPE
45.42M
23.71M
2.74M
Intangible and Goodwill Schedule
Year
2021
2020
2019
Acquisitions and Adjustments
0
0
0
Goodwill (Previous Year)
0
0
0
Goodwill
0
0
0
All figures are in USD.
